# Wound Infections Following Implant Removal

> **NCT02225821** · PHASE4 · COMPLETED · sponsor: **Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)** · enrollment: 500 (actual)

## Conditions studied

- Surgical Wound Infection

## Interventions

- **DRUG:** Cephalozin
- **OTHER:** Sodium chloride

## Key facts

- **NCT ID:** NCT02225821
- **Lead sponsor:** Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11
- **Primary completion:** 2016-11
- **Final completion:** 2016-11
- **Target enrollment:** 500 (ACTUAL)
- **Last updated:** 2016-12-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02225821

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02225821, "Wound Infections Following Implant Removal". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02225821. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*